ClinConnect ClinConnect Logo
Search / Trial NCT04688112

Validation Study of Selfie Technology for Assessment of Vital Signs

Launched by DOCME TECHNOLOGIES LTD · Dec 23, 2020

Trial Information

Current as of August 19, 2025

Enrolling by invitation

Keywords

Photoplethysmography Video Selfie Vital Signs Blood Pressure Smartphone Doc Me Heart Rate Respiratory Rate

ClinConnect Summary

Photoplethysmography (PPG) makes uses of low-intensity infrared (IR) light. When light travels through biological tissues, it is absorbed by bones, skin pigments and both venous and arterial blood. However, as light is more strongly absorbed by blood than the surrounding tissues, the changes in blood flow can be detected by PPG sensors as changes in the intensity of light.

The signal from PPG is proportional to the quantity of blood flowing through the blood vessels and even small changes in blood volume can be detected using this method. Analysis of the waveform can provide information on...

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Adults (18 - 90 years old).
  • Participants must be willing and able to give informed consent for participation in the study, and considered fit for the study by the nurse.

About Docme Technologies Ltd

Docme Technologies Ltd. is an innovative clinical trial sponsor dedicated to advancing healthcare through the development of cutting-edge digital solutions. Specializing in the integration of technology and data analytics, the company focuses on enhancing clinical research processes to improve patient outcomes and streamline trial management. With a commitment to quality and regulatory compliance, Docme Technologies Ltd. collaborates with healthcare professionals, researchers, and regulatory bodies to facilitate efficient and effective clinical trials that address unmet medical needs. Its mission is to leverage technology to drive scientific discovery and foster a more patient-centric approach in clinical research.

Locations

Oxford, Oxfordshire, United Kingdom

Patients applied

0 patients applied

Trial Officials

Alex T Novak, MRCGP FRCEM

Principal Investigator

Oxford University Hospitals NHS Trust

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials